IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection.
|
| Abstract |
The emergence of coronavirus disease 2019 (COVID-19) is globally a major healthcare threat. There is little information regarding the mechanisms and roles of the humoral response in SARS-CoV-2 infection. The aim of this study was to analyze the antibody levels (IgM and IgG) by chemiluminescence immunoassay in 54 subjects positive to SARS-CoV-2 swab test in relation to their clinical status (whether asymptomatic, pauci-symptomatic or with mild, sever or critical symptoms), the time from the symptom onset, sex, age, and comorbidities. Overall, the presence of comorbidities and the age of subjects were associated with their clinical status. The IgG concentrations were significantly higher in patients who developed critical and severe symptoms and seemed to be independent from age, sex and comorbidities. IgG titers peaked around day 60, and then began gradually to drop, decreasing by approximately 50% on the 180th day, while the IgM titers progressively decreased as early as the tenth day, but they could be detected even at later time points. Despite the small number of individuals, some peculiar characteristics of the humoral response in COVID-19 emerged. We observed a high inter-individual variability, an ephemeral IgG half-life in several patients, and a persistence of IgM in others.
|
|---|---|
| Authors | Antonella De Donno, Giambattista Lobreglio, Alessandra Panico, Tiziana Grassi, Francesco Bagordo, Maria Pia Bozzetti, Serafina Massari, Luisa Siculella, Fabrizio Damiano, Francesco Guerra, Marilena Greco, Michele Chicone, Roberta Lazzari, Pietro Alifano |
| Journal | International journal of environmental research and public health (Int J Environ Res Public Health) Vol. 18 Issue 3 (02 01 2021) ISSN: 1660-4601 [Electronic] Switzerland |
| PMID | 33535692 (Publication Type: Journal Article) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!